Chronic Lymphocytic Leukemia

Showing NaN - NaN of 64

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, CLL Progression, CLL/SLL Trial in New York (Umbralisib, Ublituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • New York, New York
    Weill Cornell Medicine
Mar 29, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
Mar 24, 2022

Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic

Withdrawn
  • CLL
  • +4 more
  • Treatment Free Observation
  • Basking Ridge, New Jersey
  • +8 more
Mar 4, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Tucson, Arizona
  • +9 more
Feb 10, 2022

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Chronic Lymphocytic Leukemia Trial in New York (thalidomide, lenalidomide, rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
Dec 23, 2021

Chronic Lymphocytic Leukemia Trial in United States (ABT-199)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +14 more
Dec 29, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

Completed
  • Chronic Lymphocytic Leukemia
  • +2 more
  • ABT-199 (Main Cohort)
  • ABT-199 (Safety Expansion Cohort)
  • Tucson, Arizona
  • +47 more
Nov 19, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Little Rock, Arkansas
  • +144 more
Dec 3, 2021

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer Trial in Worldwide (CC-115)

Completed
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +16 more
Oct 4, 2021

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +68 more
Mar 15, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

Terminated
  • Chronic Lymphocytic Leukemia
  • +7 more
  • Orange, California
  • +10 more
Oct 15, 2020

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Completed
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +105 more
Mar 2, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Bendamustine HCl, Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Birmingham, Alabama
  • +159 more
Feb 20, 2020

B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia Trial in United States (AVL-292)

Completed
  • B Cell Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +12 more
Nov 6, 2019

Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic Trial in Worldwide (lenalidomide)

Completed
  • Chronic Lymphocytic Leukemia
  • Leukemia, B-Cell, Chronic
  • Tucson, Arizona
  • +34 more
Nov 6, 2019

Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia Trial in United States (Ublituximab)

Completed
  • Non-Hodgkins Lymphoma
  • +6 more
  • Huntsville, Alabama
  • +7 more
Oct 1, 2019

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)

Terminated
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +44 more
Aug 12, 2019